Community Healthcare Trust (CHCT) Q1 2026 earnings review

Core Stability Masked by Ten-Month Tenant Saga and Falling Occupancy

Community Healthcare Trust delivered stable top-line results in 26Q1, with revenue growing 4.8% YoY to $31.5M and AFFO per share rising slightly to $0.56. However, the operational narrative is deteriorating. Portfolio occupancy broke below 90% for the first time in recent quarters, landing at 89.8%. More concerningly, the unresolved issue with a six-property geriatric behavioral hospital tenant drags on—ten months after an LOI was signed, the deal still hasn't closed. With the stock price depressing ATM equity issuance, CHCT is forced to fund its $99M acquisition pipeline through debt and asset sales, causing leverage to slowly creep upward.

🐂 Bull Case

Accretive Capital Recycling

Management successfully deployed capital into a $28.5M Florida inpatient rehabilitation facility yielding an attractive 9.3%. By funding this via revolving credit and lower-yielding asset sales, they are maintaining an accretive investment spread without diluting equity.

Unbroken Dividend Track Record

The company raised its quarterly dividend to $0.48 per share. CHCT has consistently increased its payout every quarter since going public, signaling underlying confidence in core cash flows despite tenant noise.

🐻 Bear Case

The Never-Ending Tenant Saga

An LOI to sell the operations of the troubled six-property geriatric tenant was signed in July 2025. Ten months later, due diligence is still 'finalizing.' While the tenant paid $0.3M in Q1 rent (up $0.1M QoQ), this massive delay creates significant execution risk.

Occupancy Contraction

Overall portfolio occupancy decelerated sharply, dropping from 90.6% in 25Q4 to 89.8% in 26Q1. This directly contradicts management's late-2025 claims that leasing momentum would drive occupancy into the low 90s.

⚖️ Verdict: ⚪

Neutral. Management is executing well on what they can control—acquisitions and dispositions. However, the inability to close the troubled tenant transaction and a concerning reversal in occupancy trends keep us on the sidelines.

Key Themes

CONCERN🔴

Occupancy Reversing Direction

A notable red flag in the Q1 materials is the drop in leased square footage. Occupancy reversed from a recovery trend (90.6% in 25Q4) down to 89.8% in 26Q1. During previous quarters, management had explicitly guided for occupancy growth. This miss suggests either unexpected tenant departures or a failure to backfill previously vacated spaces.

CONCERN🔴

Geriatric Tenant Resolution Stalled

The single largest overhang on CHCT remains the six-property geriatric behavioral hospital tenant. While rent collection improved slightly ($0.3M collected vs $0.2M in Q4), the core issue is the timeline. The LOI for the tenant to sell its business was signed in July 2025. Ten months is an exceptionally long due diligence period, indicating potential deal friction. Until this closes, a significant portion of potential FFO remains trapped.

DRIVER🟢

Executing the High-Yield Pipeline

Despite capital constraints, CHCT executed a key strategic acquisition: a $28.5M inpatient rehabilitation facility in Florida. With a 100% lease rate through 2044 and a 9.3% expected return, this highlights management's ability to source accretive deals. The remaining $99M pipeline (yielding 9.1%-9.75%) provides a stable, visible path to FFO growth over the next 18-24 months.

CONCERNNEW

Leverage Creep Amid Blocked Equity Markets

With the stock price depressing ATM activity (zero shares issued in Q1), CHCT is funding growth entirely through debt and asset recycling. Consequently, Net Debt to Total Capitalization ticked up to 44.0% (from 42.9% in 25Q4). While not currently in dangerous territory, the stable trend is breaking, and this strategy places a hard ceiling on external growth.

Other KPIs

Net Debt to Total Capitalization44.0%

Decelerating/Increasing. The ratio climbed from 42.9% in Q4 and 41.0% a year ago. Without access to accretive equity capital, the company's reliance on the revolving credit facility to fund $28.5M in Q1 acquisitions is structurally increasing the debt load.

Adjusted EBITDAre$22.76 million

Stable. Adjusted EBITDAre was effectively flat compared to $22.77M in 25Q4, but up 5.4% YoY from $21.60M in 25Q1. This stability proves the core portfolio is generating consistent cash flows despite the headline noise from property dispositions and tenant issues.

Guidance

Acquisition Pipeline (2026-2027)$99.0 million

Stable. Management expects to close four properties with expected returns of 9.1% to 9.75%. This is a reduction from the $122.5M pipeline cited at the end of Q4, reflecting the successful closing of the $28.5M Florida property in Q1.

Quarterly Dividend$0.48 per share

Accelerating slightly. The company bumped its dividend from $0.4775 in Q4 to $0.48, continuing its long streak of sequential quarterly dividend increases since its IPO.

Key Questions

Geriatric Tenant LOI Timeline

It has been 10 months since the LOI was signed for the geriatric behavioral hospital tenant. Is there a drop-dead date for this transaction, and what is Plan B if the buyer walks away?

Drivers of Occupancy Decline

Portfolio occupancy fell to 89.8% this quarter. What specific tenant departures drove this, and do you still expect to recover into the 'low 90s' as guided in prior quarters?

Leverage Ceiling

With the ATM paused and Net Debt to Total Capitalization reaching 44.0%, how high are you willing to let leverage drift before you pause the remaining $99M acquisition pipeline?